|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Staurosporine results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 PMID:23956101 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases expression increases activity |
ISO |
ACHE protein affects the susceptibility to [Staurosporine results in increased activity of CASP9 protein] Staurosporine results in increased expression of ACHE protein alternative form Staurosporine results in increased activity of ACHE protein |
CTD |
PMID:20338155 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adm |
adrenomedullin |
decreases expression |
ISO |
Staurosporine results in decreased expression of ADM mRNA |
CTD |
PMID:19253104 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] Staurosporine results in increased phosphorylation of AKT1 protein Staurosporine promotes the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:11306697 PMID:15177934 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Ginkgo biloba extract inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; Staurosporine promotes the reaction [PSEN2 protein mutant form results in increased expression of APP protein] |
CTD |
PMID:12556443 PMID:18001288 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atg12 |
autophagy related 12 |
affects response to substance |
ISO |
ATG12 protein affects the susceptibility to Staurosporine |
CTD |
PMID:16497721 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg7 |
autophagy related 7 |
affects response to substance |
ISO |
ATG7 protein affects the susceptibility to Staurosporine |
CTD |
PMID:16497721 |
|
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
decreases expression |
EXP |
Staurosporine results in decreased expression of ATP2A2 mRNA |
CTD |
PMID:10625299 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Bag3 |
BAG cochaperone 3 |
decreases response to substance decreases expression multiple interactions |
ISO |
BAG3 protein results in decreased susceptibility to Staurosporine Staurosporine results in decreased expression of BAG3 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Staurosporine results in increased degradation of BAG3 protein]; Staurosporine results in increased degradation of and results in increased ubiquitination of BAG3 protein |
CTD |
PMID:19352495 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Bag4 |
BAG cochaperone 4 |
decreases expression |
ISO |
Staurosporine results in decreased expression of BAG4 protein |
CTD |
PMID:19352495 |
|
NCBI chr16:66,288,678...66,305,893
Ensembl chr16:66,288,678...66,308,663
|
|
G |
Bag6 |
BAG cochaperone 6 |
decreases expression |
ISO |
Staurosporine results in decreased expression of BAG6 protein |
CTD |
PMID:19352495 |
|
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions affects localization affects expression increases expression |
ISO EXP |
Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in increased expression of BAX protein]]; Staurosporine affects the folding of and results in increased activity of BAX protein; Staurosporine promotes the reaction [Acetaldehyde results in increased expression of BAX protein]; Staurosporine promotes the reaction [BID protein binds to BAX protein]; Staurosporine results in increased activity of and results in increased expression of BAX protein Staurosporine affects the localization of BAX protein Staurosporine affects the expression of BAX mRNA Tacrine inhibits the reaction [Staurosporine results in increased expression of BAX protein] |
CTD |
PMID:11296547 PMID:12579951 PMID:15961378 PMID:16007140 PMID:19552762 PMID:35158046 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in decreased expression of BCL2 protein]]; Staurosporine inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; Staurosporine promotes the reaction [Acetaldehyde results in decreased expression of BCL2 protein] |
CTD |
PMID:15907805 PMID:35158046 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases response to substance increases expression affects expression |
ISO EXP |
BCL2L1 protein results in decreased susceptibility to Staurosporine Staurosporine results in increased expression of BCL2L1 protein alternative form Staurosporine affects the expression of BCL2L1 mRNA BCL2L1 gene mutant form results in decreased susceptibility to Staurosporine |
CTD |
PMID:10679475 PMID:10970895 PMID:11296547 PMID:11468182 PMID:21256112 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases response to substance |
ISO |
3-methyladenine inhibits the reaction [BECN1 protein results in decreased susceptibility to Staurosporine] |
CTD |
PMID:16497721 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression multiple interactions |
ISO |
Staurosporine results in increased expression of BID protein Staurosporine promotes the reaction [BID protein binds to BAX protein] |
CTD |
PMID:19552762 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases response to substance |
ISO |
BIRC3 protein results in decreased susceptibility to Staurosporine |
CTD |
PMID:16144937 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Staurosporine results in decreased expression of BIRC5 protein |
CTD |
PMID:16225760 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
affects expression |
ISO |
Staurosporine affects the expression of BUB1B mRNA |
CTD |
PMID:15721199 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Casp1 |
caspase 1 |
multiple interactions increases activity affects localization |
ISO |
Nicotine affects the reaction [Staurosporine affects the localization of CASP1 protein]; Nicotine inhibits the reaction [Staurosporine results in increased activity of CASP1 protein] |
CTD |
PMID:16927020 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp2 |
caspase 2 |
increases cleavage |
ISO |
Staurosporine results in increased cleavage of CASP2 protein |
CTD |
PMID:10663630 PMID:26124276 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases cleavage increases secretion increases activity |
ISO EXP |
Acetaminophen promotes the reaction [Staurosporine results in increased activity of CASP3 protein]; DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; ELMO1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; EOMES protein inhibits the reaction [Staurosporine results in increased expression of CASP3 protein modified form]; ginkgolide B inhibits the reaction [Staurosporine results in increased cleavage of CASP3 protein]; Lithium Chloride inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; Memantine inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; pifithrin inhibits the reaction [PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]]; PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]; quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [Staurosporine results in increased cleavage of CASP3 protein]; Rifampin inhibits the reaction [Staurosporine results in increased cleavage of CASP3 protein]; Staurosporine results in increased cleavage of and results in increased activity of CASP3 protein; Thiopental inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; Valproic Acid inhibits the reaction [Staurosporine results in increased activity of CASP3 protein] Staurosporine results in increased secretion of CASP3 protein 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP3 protein]; EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; Ibuprofen inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; IGF1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; nimesulide inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; Sirolimus inhibits the reaction [Staurosporine results in increased cleavage of CASP3 protein] HR protein affects the reaction [Staurosporine results in increased activity of CASP3 protein]; Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPTAN1 protein]; TRP53 protein affects the reaction [HR protein affects the reaction [Staurosporine results in increased activity of CASP3 protein]]; VASP mutant form promotes the reaction [Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPTAN1 protein]] |
CTD |
PMID:10663630 PMID:11296547 PMID:12556443 PMID:12871656 PMID:15909127 PMID:16007152 PMID:16225760 PMID:16402917 PMID:16497721 PMID:17045724 PMID:17051331 PMID:17245372 PMID:17996985 PMID:18178165 PMID:18182247 PMID:18218830 PMID:18832097 PMID:19101580 PMID:19352495 PMID:19406941 PMID:20302886 PMID:20886113 PMID:21534955 PMID:21864672 PMID:24132472 PMID:24260418 PMID:24912781 PMID:25586182 PMID:26124276 PMID:26775663 PMID:26963176 PMID:27392949 PMID:27539959 PMID:28450277 PMID:28747609 PMID:28975372 PMID:29140133 PMID:29410032 PMID:29458164 PMID:30660566 PMID:30905860 PMID:31758921 PMID:31926150 PMID:37268255 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases cleavage |
ISO |
Staurosporine results in increased cleavage of CASP6 protein |
CTD |
PMID:26124276 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases expression increases cleavage increases activity |
EXP ISO |
EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; IGF1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein] Staurosporine results in increased expression of CASP7 protein modified form Staurosporine results in increased cleavage of CASP7 protein DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; ELMO1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; EOMES protein inhibits the reaction [Staurosporine results in increased expression of CASP7 protein modified form] |
CTD |
PMID:16402917 PMID:18832097 PMID:19352495 PMID:19406941 PMID:21864672 PMID:24912781 PMID:25586182 PMID:26124276 PMID:27539959 More...
|
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage increases activity |
ISO |
benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Staurosporine results in increased cleavage of CASP8 protein]; Staurosporine results in increased cleavage of and results in increased activity of CASP8 protein Staurosporine results in increased activity of CASP8 protein |
CTD |
PMID:16007152 PMID:19352495 PMID:24658017 PMID:29458164 PMID:31926150 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage increases activity |
ISO EXP |
ACHE protein affects the susceptibility to [Staurosporine results in increased activity of CASP9 protein]; Staurosporine results in increased cleavage of and results in increased activity of CASP9 protein Staurosporine results in increased cleavage of CASP9 protein 3-methyladenine promotes the reaction [Staurosporine results in increased cleavage of CASP9 protein]; Sirolimus inhibits the reaction [Staurosporine results in increased cleavage of CASP9 protein] |
CTD |
PMID:16007152 PMID:16497721 PMID:19352495 PMID:20338155 PMID:26124276 PMID:29458164 PMID:31730886 PMID:31926150 PMID:34302491 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [[CXCL8 protein binds to and results in increased activity of CXCR1 protein] which results in increased phosphorylation of and affects the localization of CCR5 protein] |
CTD |
PMID:12594210 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd28 |
Cd28 molecule |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD28 protein] |
CTD |
PMID:11465111 |
|
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] |
CTD |
PMID:15978937 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] |
CTD |
PMID:16618747 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
multiple interactions affects binding |
ISO |
Staurosporine affects the reaction [KT 5720 promotes the reaction [N-Methylscopolamine binds to CHRM1 protein]]; Staurosporine affects the reaction [muscarinic toxin 7 binds to CHRM1 protein]; Staurosporine promotes the reaction [N-Methylscopolamine binds to CHRM1 protein] Staurosporine binds to CHRM1 protein |
CTD |
PMID:10860942 PMID:16439611 |
|
NCBI chr 1:205,567,226...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
ISO |
Staurosporine promotes the reaction [N-Methylscopolamine binds to CHRM2 protein] |
CTD |
PMID:10860942 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
affects binding |
EXP |
Staurosporine binds to CHRM3 protein |
CTD |
PMID:12435818 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Ginkgo biloba extract inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]] |
CTD |
PMID:18001288 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]] |
CTD |
PMID:2153673 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
ISO |
CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with Staurosporine] |
CTD |
PMID:8471626 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csn2 |
casein beta |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [[INS1 protein co-treated with PRL protein] results in increased expression of CSN2 mRNA] |
CTD |
PMID:7648427 |
|
NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
multiple interactions |
ISO |
Staurosporine affects the reaction [Formaldehyde affects the phosphorylation of CSNK2A1 protein] |
CTD |
PMID:36534342 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2a2 |
casein kinase 2 alpha 2 |
affects expression |
ISO |
Staurosporine affects the expression of CSNK2A2 mRNA |
CTD |
PMID:15721199 |
|
NCBI chr19:9,556,443...9,596,080
Ensembl chr19:9,556,260...9,596,080
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases phosphorylation |
EXP |
Staurosporine results in increased phosphorylation of CTNNB1 protein |
CTD |
PMID:19741129 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [[CXCL8 protein binds to and results in increased activity of CXCR1 protein] which results in increased phosphorylation of and affects the localization of CCR5 protein]; Staurosporine inhibits the reaction [[CXCL8 protein binds to and results in increased activity of CXCR1 protein] which results in increased phosphorylation of CXCR4 protein] |
CTD |
PMID:12594210 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [[CXCL8 protein binds to and results in increased activity of CXCR1 protein] which results in increased phosphorylation of CXCR4 protein] |
CTD |
PMID:12594210 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of CYBB protein] |
CTD |
PMID:29183754 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; Staurosporine inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; Staurosporine inhibits the reaction [Omeprazole results in increased expression of CYP1A1 protein] |
CTD |
PMID:1312672 PMID:7587946 PMID:9395520 PMID:10696073 PMID:15947024 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression |
EXP |
Staurosporine inhibits the reaction [INS1 protein results in decreased expression of CYP2E1 mRNA] Staurosporine results in increased expression of CYP2E1 mRNA |
CTD |
PMID:11306697 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Calcitriol results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:17965521 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Staurosporine results in increased expression of DDIT3 mRNA |
CTD |
PMID:32870474 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dedd |
death effector domain-containing |
affects expression |
ISO |
Staurosporine affects the expression of DEDD mRNA |
CTD |
PMID:15721199 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Dock1 |
dedicator of cyto-kinesis 1 |
multiple interactions |
ISO |
DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein] |
CTD |
PMID:25586182 |
|
NCBI chr 1:189,467,143...189,983,777
Ensembl chr 1:189,467,143...189,983,768
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
multiple interactions decreases expression |
EXP |
Staurosporine inhibits the reaction [MBF1 protein results in increased secretion of NPPA protein] Staurosporine results in decreased expression of MBF1 protein |
CTD |
PMID:12729799 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Edn1 |
endothelin 1 |
decreases activity |
EXP |
Staurosporine results in decreased activity of EDN1 protein |
CTD |
PMID:15464066 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; Staurosporine inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein] |
CTD |
PMID:20561571 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein] |
CTD |
PMID:15542774 PMID:19406941 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
CTD |
PMID:15177934 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases activity |
ISO |
Staurosporine results in decreased activity of EIF2AK2 protein |
CTD |
PMID:12890478 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
Staurosporine results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:21090173 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
multiple interactions |
ISO |
ELMO1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; ELMO1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein] |
CTD |
PMID:25586182 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Eomes |
eomesodermin |
multiple interactions |
ISO |
EOMES protein inhibits the reaction [Staurosporine results in increased cleavage of PARP1 protein]; EOMES protein inhibits the reaction [Staurosporine results in increased expression of CASP3 protein modified form]; EOMES protein inhibits the reaction [Staurosporine results in increased expression of CASP7 protein modified form] |
CTD |
PMID:27539959 |
|
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
|
|
G |
Epo |
erythropoietin |
decreases response to substance multiple interactions |
EXP |
EPO protein results in decreased susceptibility to Staurosporine tin mesoporphyrin inhibits the reaction [EPO protein results in decreased susceptibility to Staurosporine] |
CTD |
PMID:15816862 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Ercc5 |
ERCC excision repair 5, endonuclease |
affects expression |
ISO |
Staurosporine affects the expression of ERCC5 mRNA |
CTD |
PMID:15721199 |
|
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of ESR2 protein |
CTD |
PMID:25752796 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Asbestos, Crocidolite results in increased expression of F3 mRNA] |
CTD |
PMID:15371228 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
affects expression |
ISO |
Staurosporine affects the expression of FERMT2 mRNA |
CTD |
PMID:15721199 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [Acetaldehyde results in increased expression of FN1 mRNA] |
CTD |
PMID:7945571 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [Acetaldehyde results in increased expression of FOS mRNA]; Staurosporine inhibits the reaction [Cadmium Chloride results in increased expression of FOS mRNA] |
CTD |
PMID:7945571 PMID:9417049 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
Staurosporine promotes the reaction [MYC protein binds to GCLC promoter] |
CTD |
PMID:17628013 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
ISO |
Staurosporine promotes the reaction [MYC protein binds to GCLM promoter] |
CTD |
PMID:17628013 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of GFAP protein] |
CTD |
PMID:21879721 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Grp |
gastrin releasing peptide |
multiple interactions |
ISO |
Staurosporine promotes the reaction [GRP protein modified form results in increased chemical synthesis of Inositol Phosphates] |
CTD |
PMID:18313772 |
|
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of GSTA2 protein] |
CTD |
PMID:7587946 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Staurosporine inhibits the reaction [Acrolein results in increased expression of HMOX1 mRNA]; Staurosporine inhibits the reaction [Smoke analog results in increased expression of HMOX1 protein]; Staurosporine inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein] Staurosporine results in increased expression of HMOX1 protein SOD2 mutant form inhibits the reaction [Staurosporine results in increased expression of HMOX1 protein]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein] |
CTD |
PMID:12788823 PMID:18048804 PMID:23290930 PMID:24740755 PMID:28108387 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hr |
HR, lysine demethylase and nuclear receptor corepressor |
multiple interactions affects response to substance |
ISO EXP |
HR protein affects the reaction [Staurosporine results in increased activity of CASP3 protein]; TRP53 protein affects the reaction [HR protein affects the reaction [Staurosporine results in increased activity of CASP3 protein]] HR protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; HR protein inhibits the reaction [Staurosporine results in increased expression of TP53 protein] HR protein affects the susceptibility to Staurosporine |
CTD |
PMID:20886113 |
|
NCBI chr15:45,626,835...45,646,313
Ensembl chr15:45,626,835...45,646,313
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions affects activity |
EXP |
IGF1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; IGF1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein] Staurosporine affects the activity of IGF1 protein |
CTD |
PMID:11548882 PMID:19406941 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Il33 |
interleukin 33 |
multiple interactions increases expression |
ISO |
N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Staurosporine results in increased expression of IL33 protein] |
CTD |
PMID:25747661 |
|
NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [IL4 protein promotes the reaction [Ionomycin results in increased expression of TNFRSF4 protein]]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [IL4 protein results in increased expression of TNFRSF4 protein]] |
CTD |
PMID:9766631 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
decreases activity |
ISO |
Staurosporine results in decreased activity of IL5 protein |
CTD |
PMID:12562334 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [[INS1 protein co-treated with PRL protein] results in increased expression of CSN2 mRNA] Staurosporine inhibits the reaction [INS1 protein results in decreased expression of CYP2E1 mRNA]; Staurosporine promotes the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:7648427 PMID:11306697 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [INS protein results in increased uptake of cobaltous chloride] |
CTD |
PMID:14622148 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Itgal |
integrin subunit alpha L |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL mRNA]; Staurosporine inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAL protein]; Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL protein] |
CTD |
PMID:10198263 |
|
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGAM protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGAM protein] |
CTD |
PMID:18500357 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb2 |
integrin subunit beta 2 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein] |
CTD |
PMID:16393473 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases phosphorylation |
EXP |
Staurosporine inhibits the reaction [Acetaldehyde results in increased expression of JUN mRNA] Staurosporine results in increased phosphorylation of JUN protein |
CTD |
PMID:7945571 PMID:9751194 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kng1 |
kininogen 1 |
decreases activity |
EXP |
Staurosporine results in decreased activity of KNG1 |
CTD |
PMID:1334751 |
|
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CGB3 protein results in increased chemical synthesis of Cyclic AMP]] |
CTD |
PMID:2153673 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lmna |
lamin A/C |
increases cleavage |
ISO |
Staurosporine results in increased cleavage of LMNA protein |
CTD |
PMID:26124276 |
|
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein]]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein]; Staurosporine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK1 protein]; Staurosporine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] Staurosporine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11035063 PMID:15177934 PMID:15542774 PMID:16251475 PMID:17003101 PMID:19699794 PMID:21879721 More...
|
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein]]; Staurosporine inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein]; Staurosporine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK3 protein]; Staurosporine inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] Staurosporine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK3 protein] Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11035063 PMID:15177934 PMID:15542774 PMID:16251475 PMID:17003101 PMID:19699794 PMID:21879721 More...
|
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [oxophenylarsine results in increased phosphorylation of MAPT protein] |
CTD |
PMID:10737602 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Mark1 |
microtubule affinity regulating kinase 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [oxophenylarsine results in increased activity of MARK1 protein] |
CTD |
PMID:10737602 |
|
NCBI chr13:96,450,189...96,555,304
Ensembl chr13:96,451,487...96,555,173
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
increases cleavage decreases response to substance |
ISO |
Staurosporine results in increased cleavage of MCL1 protein MCL1 results in decreased susceptibility to Staurosporine |
CTD |
PMID:15217956 PMID:16007152 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]] |
CTD |
PMID:15542774 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Homocysteine results in increased activity of MMP9 protein]; Staurosporine inhibits the reaction [Homocysteine results in increased expression of MMP9 protein] |
CTD |
PMID:16251475 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Cadmium Chloride results in increased expression of MT1 mRNA]; Staurosporine inhibits the reaction [Zinc Sulfate results in increased expression of MT1 mRNA] |
CTD |
PMID:15142038 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions decreases response to substance |
ISO |
MYC protein inhibits the reaction [Staurosporine results in increased abundance of Reactive Oxygen Species]; Staurosporine promotes the reaction [MYC protein binds to GCLC promoter]; Staurosporine promotes the reaction [MYC protein binds to GCLM promoter] MYC protein results in decreased susceptibility to Staurosporine |
CTD |
PMID:17628013 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nefl |
neurofilament light chain |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFL protein] |
CTD |
PMID:21879721 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nefm |
neurofilament medium chain |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of NEFM protein] |
CTD |
PMID:21879721 |
|
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
ISO |
Staurosporine inhibits the reaction [Ethanol affects the localization of NFE2L2 protein]; Staurosporine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein] Staurosporine results in decreased expression of NFE2L2 protein modified form |
CTD |
PMID:22530035 PMID:30703377 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [bisphenol A results in increased expression of NFKB1 protein] |
CTD |
PMID:20499049 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [NGF results in increased susceptibility to Capsaicin] Staurosporine inhibits the reaction [NGF protein results in increased uptake of Calcium] |
CTD |
PMID:1374475 PMID:12815188 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [ginsenoside Rg3 results in increased expression of NOS2 protein] |
CTD |
PMID:14534150 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [MBF1 protein results in increased secretion of NPPA protein] |
CTD |
PMID:12729799 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP ISO |
Staurosporine inhibits the reaction [benz(a)anthracene results in increased activity of NQO1 protein] Staurosporine inhibits the reaction [Smoke analog results in increased expression of NQO1 protein] |
CTD |
PMID:7587946 PMID:28108387 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ntf3 |
neurotrophin 3 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [Histamine results in increased expression of NTF3 protein]; Staurosporine inhibits the reaction [imetit results in increased expression of NTF3 protein]; Staurosporine inhibits the reaction [methylhistaprodifen results in increased expression of NTF3 protein]; Staurosporine inhibits the reaction [Neurotransmitter Agents results in increased expression of NTF3 protein] |
CTD |
PMID:19854260 PMID:21276809 |
|
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Nts |
neurotensin |
multiple interactions increases activity |
ISO |
Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein]; Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein]; Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Staurosporine inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased activity of NTS protein]; Staurosporine promotes the reaction [NTS protein results in increased chemical synthesis of Inositol Phosphates]; Tetradecanoylphorbol Acetate inhibits the reaction [Staurosporine results in increased activity of NTS protein] |
CTD |
PMID:15177934 PMID:18313772 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases expression increases cleavage |
ISO EXP |
SOD2 mutant form inhibits the reaction [Staurosporine results in increased cleavage of PARP1 protein]; Staurosporine affects the reaction [sodium arsenite results in increased cleavage of PARP1 protein] Staurosporine results in increased expression of PARP1 protein modified form EOMES protein inhibits the reaction [Staurosporine results in increased cleavage of PARP1 protein]; Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in increased cleavage of PARP1 protein]]; Staurosporine promotes the reaction [Acetaldehyde results in increased cleavage of PARP1 protein] |
CTD |
PMID:10704466 PMID:11035063 PMID:18451153 PMID:21447800 PMID:22639866 PMID:24464939 PMID:24740755 PMID:27539959 PMID:30660566 PMID:35158046 PMID:37268255 More...
|
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Staurosporine] results in increased acetylation of PPARGC1A protein; resveratrol inhibits the reaction [[Hydrogen Peroxide co-treated with Staurosporine] results in increased acetylation of PPARGC1A protein] |
CTD |
PMID:23293585 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
affects localization |
EXP |
Staurosporine affects the localization of PPP2R2B protein |
CTD |
PMID:18940801 |
|
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
decreases response to substance increases cleavage |
ISO |
PPP3CA protein results in decreased susceptibility to Staurosporine Staurosporine results in increased cleavage of PPP3CA protein |
CTD |
PMID:10679475 PMID:10898953 |
|
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [sodium arsenate results in increased expression of PRDX1 protein] |
CTD |
PMID:11796722 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO EXP |
Staurosporine affects the localization of and affects the activity of PRKCA protein [linsidomine co-treated with Staurosporine] results in decreased expression of PRKCA protein; Staurosporine inhibits the reaction [Heptachlor affects the localization of PRKCA protein]; Staurosporine inhibits the reaction [linsidomine results in increased phosphorylation of PRKCA protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein] |
CTD |
PMID:11994256 PMID:14678745 PMID:16225760 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [Curcumin results in increased phosphorylation of PRKCD protein] Staurosporine inhibits the reaction [Heptachlor affects the localization of PRKCD protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCD protein] |
CTD |
PMID:14678745 PMID:17171638 |
|
NCBI chr16:5,769,217...5,799,380
Ensembl chr16:5,769,215...5,799,352
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [[INS1 protein co-treated with PRL protein] results in increased expression of CSN2 mRNA] |
CTD |
PMID:7648427 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Psen2 |
presenilin 2 |
multiple interactions |
ISO |
pifithrin inhibits the reaction [PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]]; PSEN2 protein mutant form promotes the reaction [Staurosporine results in increased activity of CASP3 protein]; Staurosporine promotes the reaction [PSEN2 protein mutant form results in increased expression of APP protein] |
CTD |
PMID:12556443 |
|
NCBI chr13:91,967,506...91,993,240
Ensembl chr13:91,967,983...91,993,174
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
multiple interactions decreases phosphorylation |
EXP |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PTGER3 protein alternative form] Staurosporine results in decreased phosphorylation of PTGER3 protein alternative form |
CTD |
PMID:15937517 |
|
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
increases cleavage |
ISO |
Staurosporine results in increased cleavage of PTGES3 protein |
CTD |
PMID:26124276 |
|
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Nicotine results in increased expression of PTGS2] |
CTD |
PMID:17003101 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein]; Staurosporine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of RELA protein] Staurosporine inhibits the reaction [bisphenol A results in increased expression of RELA protein] |
CTD |
PMID:20499049 PMID:24021941 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ret |
ret proto-oncogene |
decreases expression |
EXP |
Staurosporine results in decreased expression of RET protein |
CTD |
PMID:17555550 |
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SDHB protein; resveratrol inhibits the reaction [[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SDHB protein] |
CTD |
PMID:23293585 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Set |
Set nuclear proto-oncogene |
multiple interactions |
ISO |
Staurosporine affects the reaction [Formaldehyde affects the localization of SET protein alternative form] |
CTD |
PMID:36534342 |
|
NCBI chr 3:13,334,564...13,345,598
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SIRT1 protein; resveratrol inhibits the reaction [[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SIRT1 protein] |
CTD |
PMID:23293585 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions decreases phosphorylation |
ISO |
[Staurosporine results in decreased phosphorylation of SLC11A2 protein] which results in decreased uptake of Iron |
CTD |
PMID:27681840 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc12a5 |
solute carrier family 12 member 5 |
increases activity multiple interactions |
ISO |
Staurosporine results in increased activity of SLC12A5 protein Staurosporine inhibits the reaction [SLC12A5 protein results in increased import of Thallium] |
CTD |
PMID:20086212 |
|
NCBI chr 3:153,696,517...153,735,801
Ensembl chr 3:153,696,517...153,735,765
|
|
G |
Slc1a1 |
solute carrier family 1 member 1 |
multiple interactions decreases activity |
EXP |
Staurosporine inhibits the reaction [Pregabalin results in increased activity of SLC1A1 protein]; Staurosporine inhibits the reaction [Progesterone results in increased activity of SLC1A1 protein] Staurosporine results in decreased activity of SLC1A1 protein |
CTD |
PMID:17382927 PMID:22511482 PMID:23262392 PMID:23602688 PMID:24355585 |
|
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC1A2 protein] |
CTD |
PMID:26988466 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Slc22a25 |
solute carrier family 22, member 25 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Phorbol 12,13-Dibutyrate affects the localization of SLC22A9 protein]; Staurosporine inhibits the reaction [Phorbol 12,13-Dibutyrate results in decreased activity of SLC22A9 protein] |
CTD |
PMID:17341544 |
|
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
|
|
G |
Slc30a1 |
solute carrier family 30 member 1 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Zinc Sulfate results in increased expression of SLC30A1 mRNA] |
CTD |
PMID:15142038 |
|
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
multiple interactions increases activity |
ISO |
SNCA protein affects the reaction [Staurosporine results in increased activity of SLC6A3 protein] |
CTD |
PMID:19032594 |
|
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
increases activity |
ISO |
staurosporine increases activity of SLC6A4 protein in placental choriocarcinoma cells |
RGD |
PMID:7615516 |
RGD:38500207 |
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
[Staurosporine co-treated with Rotenone] promotes the reaction [SNCA protein binds to SNCA protein]; SNCA protein affects the reaction [Staurosporine results in increased activity of SLC6A3 protein] |
CTD |
PMID:19032594 PMID:19114014 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SOD2 protein; resveratrol inhibits the reaction [[Hydrogen Peroxide co-treated with Staurosporine] results in decreased expression of SOD2 protein]; SOD2 mutant form inhibits the reaction [Staurosporine results in increased cleavage of PARP1 protein]; SOD2 mutant form inhibits the reaction [Staurosporine results in increased expression of HMOX1 protein] |
CTD |
PMID:23293585 PMID:24740755 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
multiple interactions increases cleavage |
ISO |
Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPTAN1 protein]; VASP mutant form promotes the reaction [Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPTAN1 protein]] Staurosporine results in increased cleavage of SPTAN1 protein |
CTD |
PMID:18182247 PMID:21683092 PMID:26124276 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:18448488 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein] |
CTD |
PMID:19331829 |
|
NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases activity |
ISO |
Staurosporine results in decreased activity of TERT protein |
CTD |
PMID:9434777 |
|
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of THRA protein |
CTD |
PMID:25752796 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
Staurosporine binds to and results in decreased activity of THRB protein |
CTD |
PMID:25752796 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein] |
CTD |
PMID:16716901 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL mRNA]; Staurosporine inhibits the reaction [TNF protein results in increased expression of ITGAL protein] |
CTD |
PMID:10198263 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf4 |
TNF receptor superfamily member 4 |
multiple interactions increases expression |
EXP |
Staurosporine inhibits the reaction [IL4 protein promotes the reaction [Ionomycin results in increased expression of TNFRSF4 protein]]; Staurosporine inhibits the reaction [Ionomycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF4 protein]]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [IL4 protein results in increased expression of TNFRSF4 protein]]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF4 protein]; Staurosporine promotes the reaction [Mercuric Chloride results in increased expression of TNFRSF4 protein] Staurosporine results in increased expression of TNFRSF4 protein |
CTD |
PMID:9766631 |
|
NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO EXP |
Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]]; Staurosporine promotes the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein] TRP53 protein affects the reaction [HR protein affects the reaction [Staurosporine results in increased activity of CASP3 protein]] HR protein inhibits the reaction [Staurosporine results in increased expression of TP53 protein] |
CTD |
PMID:15542774 PMID:20886113 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
multiple interactions |
ISO |
VASP mutant form promotes the reaction [Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPTAN1 protein]] |
CTD |
PMID:18182247 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
multiple interactions |
EXP |
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Staurosporine promotes the reaction [VDAC1 protein binds to VDAC1 protein]]; Staurosporine promotes the reaction [VDAC1 protein binds to VDAC1 protein] |
CTD |
PMID:20937774 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|
G |
Vdr |
vitamin D receptor |
increases cleavage |
ISO |
Staurosporine results in increased cleavage of VDR protein |
CTD |
PMID:18832097 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Staurosporine inhibits the reaction [VEGFA protein results in increased abundance of phosphatidylbutanol]; Staurosporine inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein] |
CTD |
PMID:12788823 PMID:14704231 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP |
Staurosporine inhibits the reaction [diphenylditelluride results in increased phosphorylation of VIM protein] |
CTD |
PMID:21879721 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wt1 |
WT1 transcription factor |
increases expression |
ISO |
Staurosporine results in increased expression of WT1 protein |
CTD |
PMID:12914969 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity |
ISO |
midostaurin results in decreased activity of ABCB1 protein |
CTD |
PMID:11836167 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
midostaurin inhibits the reaction [AGT protein results in increased abundance of Epoprostenol] |
CTD |
PMID:14613874 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
multiple interactions decreases activity |
ISO |
midostaurin inhibits the reaction [AKR1C3 protein results in decreased susceptibility to Daunorubicin]; midostaurin inhibits the reaction [AKR1C3 protein results in increased metabolism of Daunorubicin] midostaurin results in decreased activity of AKR1C3 protein |
CTD |
PMID:33025066 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
midostaurin promotes the reaction [Loratadine results in increased activity of CASP3 protein]; midostaurin promotes the reaction [Terfenadine results in increased activity of CASP3 protein] |
CTD |
PMID:20570632 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
midostaurin inhibits the reaction [EGF protein inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] |
CTD |
PMID:15542774 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
decreases activity |
ISO |
midostaurin results in decreased activity of FGFR3 protein |
CTD |
PMID:16091734 |
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Flt3 |
Fms related receptor tyrosine kinase 3 |
decreases response to substance decreases activity |
ISO |
FLT3 protein results in decreased susceptibility to midostaurin midostaurin results in decreased activity of FLT3 protein |
CTD |
PMID:21980431 |
|
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
|
|
G |
Gypa |
glycophorin A |
decreases expression |
ISO |
midostaurin results in decreased expression of GYPA protein |
CTD |
PMID:19573588 |
|
NCBI chr19:27,450,304...27,465,940
Ensembl chr19:27,450,308...27,465,822
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
midostaurin inhibits the reaction [KIT protein polymorphism results in increased expression of HMOX1 protein] |
CTD |
PMID:17420286 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Itgb3 |
integrin subunit beta 3 |
multiple interactions |
ISO |
midostaurin results in increased expression of and results in increased localization of ITGB3 protein |
CTD |
PMID:19573588 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
multiple interactions |
ISO |
midostaurin inhibits the reaction [KIT protein polymorphism results in increased expression of HMOX1 protein] |
CTD |
PMID:17420286 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
midostaurin affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK1 protein] |
CTD |
PMID:15542774 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
midostaurin affects the reaction [resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of MAPK3 protein] |
CTD |
PMID:15542774 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mpl |
MPL proto-oncogene, thrombopoietin receptor |
increases expression |
ISO |
midostaurin results in increased expression of MPL protein |
CTD |
PMID:19573588 |
|
NCBI chr 5:131,973,895...131,987,472
Ensembl chr 5:131,973,895...131,986,797
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
midostaurin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:14613874 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
midostaurin affects the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]; midostaurin inhibits the reaction [EGF protein inhibits the reaction [Resveratrol results in increased phosphorylation of and results in increased activity of and results in increased localization of TP53 protein]] |
CTD |
PMID:15542774 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|